News
-
Is Amazon’s Approach With HealthScribe Favoring Collaboration Over Competition Smart?
Amazon recently unveiled HealthScribe, an API that software companies can use to create clinical note generation apps that providers can later adopt. With this approach, Amazon is seeking to collaborate with companies that are building clinical documentation AI apps rather than compete with them. Some think this approach is clever, but others think it does little to facilitate bi-directional EHR integration and create standardization.
-
Artificial Intelligence, BioPharma
Sumitomo Schizophrenia Drug Discovered With AI Tech Fails in Two Phase 3 Trials
A schizophrenia drug candidate from partners Sumitomo Pharma and Otsuka Pharmaceutical failed to outperform a placebo in two Phase 3 studies. The compound is the most advanced program from a psychiatry and neurology collaboration spanning four drugs discovered by an artificial intelligence technology platform.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes
Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug’s effect on the body, and more.
-
How My Brother’s Death Changed The Way I Think About Mental Health Care
As clinical psychologists, we talk about therapy as the gold standard. I’m not saying it isn’t, but if only a minority of people are getting it, we need to broaden our perspective.
-
Hospital Downtime Planning: The Right Strategy & Technology to Ensure Uninterrupted Patient Care
It’s never a question of whether a hospital will experience downtime — it’s a matter of when. Adopting the right downtime technology means hospitals can cut costs, reduce stress on staff and mitigate risk of cyberattack by automatically encrypting data to HIPAA standards.
-
BioPharma, Consumer / Employer, Devices & Diagnostics, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences
In this month’s episode, we dive into some recent executive appointments occurring in the healthcare world, as well as layoffs affecting the industry. We also hear from Leslie Orne, who recently became the new CEO of Trinity Life Sciences, which provides consulting services and technology solutions to life sciences firms looking to commercialize their product.
-
A Nonprofit Pharma Nabs FDA Nod for Nonprescription Naloxone Nasal Spray
The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.
-
Biogen Bulks Up in Rare Disease With $7.3B Reata Pharmaceuticals Acquisition
Biogen’s Reata Pharmaceuticals acquisition brings Skyclarys, the first and only FDA-approved therapy for the rare neuromuscular disease Friedreich’s ataxia. Biogen says Skyclarys complements the other neuromuscular drugs in its portfolio.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
How Geisinger, UNC Health Are Deploying Predictive Algorithms
Executives from Geisinger and UNC Health discussed the most impactful ways they have deployed predictive AI across their health systems during a recent virtual panel. At Geisinger, these predictive algorithms are reducing avoidable emergency department admissions, and at UNC, they are helping to identify sepsis before it becomes severe.
-
RapidAI Rakes In $75M to Accelerate Stroke Diagnosis
RapidAI recently closed a $75 million Series C funding round led by Vista Credit Partners. The company offers an AI platform that helps hospital care teams triage and treat stroke patients more quickly.
-
MedCity Influencers, BioPharma
Clinical Trials Have A Data Problem. Here’s How The Industry Can Solve It.
To maximize the digital clinical trial opportunity, it is imperative to establish a solid foundation of data collection and management best practices and capitalize on the advancements in data management technologies.
-
Bio Startup Nexo Lands $60M to Climb to New Heights in Cancer Drug R&D
Nexo Therapeutics is developing cancer drugs that expand the scope of amino acids addressable by covalent chemistry. Versant Ventures founded the startup and led its Series A financing.
-
MedCity Influencers, Devices & Diagnostics
Medical Devices Are Evolving Toward Specialized Solutions
Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations […]
-
Consumer / Employer, Health Tech
GoodRx Launches Solution To Help Consumers Manage Their Prescriptions
Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.
-
NorthShore Study Proves Hospitals Can Save Millions by Providing Post-Discharge Psychosocial Support
NorthShore University HealthSystem teamed up with Laguna Health in 2021 to study whether greater post-acute care support can improve patient recovery and reduce readmissions. The research partners recently released results of the study, which found that giving patients emotional and psychological support after their discharge hastens recovery, decreases costs and alleviates physician burnout.
-
FDA Refuses to Review Biohaven Drug for Rare Neuromuscular Disease With No Treatments
Biohaven’s bid to bring to market the first drug for rare neuromuscular disorder spinocerebellar ataxia has hit a setback. The FDA is refusing to review the drug’s application, a decision that could indicate the agency wants another clinical trial.
-
6 Ways Providers Can Better Manage 3rd-Party Cybersecurity Risks
The Health3PT Initiative recently released recommendations on how providers can better address the cybersecurity risks linked to their third party reliance. Some of the group’s recommendations included ensuring that contract language ties financial terms to a vendor’s data management transparency and establishing metrics and reporting requirements for organization-wide vendor risks.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
